Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Determination of virulence and fitness genes associated with the pheU, pheV and selC integration sites of LEE-negative food-borne Shiga toxin-producing Escherichia coli strains.

Saile N, Schuh E, Semmler T, Eichhorn I, Wieler LH, Bauwens A, Schmidt H.

Gut Pathog. 2018 Oct 8;10:43. doi: 10.1186/s13099-018-0271-8. eCollection 2018.

2.

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.

Chan A, Bauwens A, Pontre S, Jackson S, McGlone F, Ernenwein T, Chih J, Reid C.

Breast. 2018 Oct;41:127-132. doi: 10.1016/j.breast.2018.07.006. Epub 2018 Jul 18.

PMID:
30048865
3.

Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB.

Bielaszewska M, Marejková M, Bauwens A, Kunsmann-Prokscha L, Mellmann A, Karch H.

Int J Med Microbiol. 2018 Oct;308(7):882-889. doi: 10.1016/j.ijmm.2018.06.004. Epub 2018 Jun 19.

PMID:
29934223
4.

Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H- Isolates from Czech Patients with Novel Plasmid Composition Not Previously Seen in German Isolates.

Bauwens A, Marejková M, Middendorf-Bauchart B, Prager R, Kossow A, Zhang W, Karch H, Mellmann A, Bielaszewska M.

Appl Environ Microbiol. 2017 Nov 16;83(23). pii: e01454-17. doi: 10.1128/AEM.01454-17. Print 2017 Dec 1.

5.

Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).

Chan A, De Boer R, Gan A, Willsher P, Martin R, Zissiadis Y, Miller K, Bauwens A, Hastrich D.

Support Care Cancer. 2017 Dec;25(12):3785-3791. doi: 10.1007/s00520-017-3810-9. Epub 2017 Jul 9.

PMID:
28691132
6.

Intrahost milieu modulates production of outer membrane vesicles, vesicle-associated Shiga toxin 2a and cytotoxicity in Escherichia coli O157:H7 and O104:H4.

Bauwens A, Kunsmann L, Marejková M, Zhang W, Karch H, Bielaszewska M, Mellmann A.

Environ Microbiol Rep. 2017 Oct;9(5):626-634. doi: 10.1111/1758-2229.12562. Epub 2017 Jul 21.

PMID:
28675605
7.

Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.

Bauwens A, Kunsmann L, Karch H, Mellmann A, Bielaszewska M.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00937-17. doi: 10.1128/AAC.00937-17. Print 2017 Sep.

8.

Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury.

Bielaszewska M, Rüter C, Bauwens A, Greune L, Jarosch KA, Steil D, Zhang W, He X, Lloubes R, Fruth A, Kim KS, Schmidt MA, Dobrindt U, Mellmann A, Karch H.

PLoS Pathog. 2017 Feb 3;13(2):e1006159. doi: 10.1371/journal.ppat.1006159. eCollection 2017 Feb.

9.

On-Tissue Phospholipase C Digestion for Enhanced MALDI-MS Imaging of Neutral Glycosphingolipids.

Vens-Cappell S, Kouzel IU, Kettling H, Soltwisch J, Bauwens A, Porubsky S, Müthing J, Dreisewerd K.

Anal Chem. 2016 Jun 7;88(11):5595-9. doi: 10.1021/acs.analchem.6b01084. Epub 2016 May 26.

PMID:
27212679
10.

Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes.

Betz J, Dorn I, Kouzel IU, Bauwens A, Meisen I, Kemper B, Bielaszewska M, Mormann M, Weymann L, Sibrowski W, Karch H, Schlenke P, Müthing J.

Cell Microbiol. 2016 Oct;18(10):1339-48. doi: 10.1111/cmi.12592. Epub 2016 Apr 29.

PMID:
26990252
11.

Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain.

Kunsmann L, Rüter C, Bauwens A, Greune L, Glüder M, Kemper B, Fruth A, Wai SN, He X, Lloubes R, Schmidt MA, Dobrindt U, Mellmann A, Karch H, Bielaszewska M.

Sci Rep. 2015 Aug 18;5:13252. doi: 10.1038/srep13252.

12.

Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.

Chan A, Shannon C, de Boer R, Baron-Hay S, Redfern A, Bauwens A, Craft P, Webb S, Townsend A, Kotasek D.

Asia Pac J Clin Oncol. 2014 Dec;10(4):368-75. doi: 10.1111/ajco.12292. Epub 2014 Oct 28.

PMID:
25351929
13.

Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence.

Bielaszewska M, Aldick T, Bauwens A, Karch H.

Int J Med Microbiol. 2014 Jul;304(5-6):521-9. doi: 10.1016/j.ijmm.2014.05.005. Epub 2014 May 15. Review.

PMID:
24933303
14.

Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2:H6.

Bielaszewska M, Schiller R, Lammers L, Bauwens A, Fruth A, Middendorf B, Schmidt MA, Tarr PI, Dobrindt U, Karch H, Mellmann A.

EMBO Mol Med. 2014 Mar;6(3):347-57. doi: 10.1002/emmm.201303133. Epub 2014 Jan 10.

15.

Enterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosis.

Bielaszewska M, Rüter C, Kunsmann L, Greune L, Bauwens A, Zhang W, Kuczius T, Kim KS, Mellmann A, Schmidt MA, Karch H.

PLoS Pathog. 2013;9(12):e1003797. doi: 10.1371/journal.ppat.1003797. Epub 2013 Dec 12.

16.

Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans.

Zhang W, Bielaszewska M, Kunsmann L, Mellmann A, Bauwens A, Köck R, Kossow A, Anders A, Gatermann S, Karch H.

PLoS One. 2013 Jun 21;8(6):e66717. doi: 10.1371/journal.pone.0066717. Print 2013.

17.

Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Kouzel IU, Pohlentz G, Storck W, Radamm L, Hoffmann P, Bielaszewska M, Bauwens A, Cichon C, Schmidt MA, Mormann M, Karch H, Müthing J.

J Lipid Res. 2013 Mar;54(3):692-710. doi: 10.1194/jlr.M031781. Epub 2012 Dec 17.

18.

Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Müthing J.

Cell Mol Life Sci. 2013 Feb;70(3):425-57. doi: 10.1007/s00018-012-1060-z. Epub 2012 Jul 6. Review.

PMID:
22766973
19.

Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.

Betz J, Bauwens A, Kunsmann L, Bielaszewska M, Mormann M, Humpf HU, Karch H, Friedrich AW, Müthing J.

Biol Chem. 2012 Mar;393(3):133-47. doi: 10.1515/hsz-2011-0288.

PMID:
22718629
20.

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, Peters G, Karch H.

Antimicrob Agents Chemother. 2012 Jun;56(6):3277-82. doi: 10.1128/AAC.06315-11. Epub 2012 Mar 5.

21.

Real-time multiplex PCR for detecting Shiga toxin 2-producing Escherichia coli O104:H4 in human stools.

Zhang W, Bielaszewska M, Bauwens A, Fruth A, Mellmann A, Karch H.

J Clin Microbiol. 2012 May;50(5):1752-4. doi: 10.1128/JCM.06817-11. Epub 2012 Feb 15.

22.

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.

Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H.

Lancet Infect Dis. 2011 Sep;11(9):671-6. doi: 10.1016/S1473-3099(11)70165-7. Epub 2011 Jun 22.

PMID:
21703928
23.

Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells.

Bauwens A, Bielaszewska M, Kemper B, Langehanenberg P, von Bally G, Reichelt R, Mulac D, Humpf HU, Friedrich AW, Kim KS, Karch H, Müthing J.

Thromb Haemost. 2011 Mar;105(3):515-28. doi: 10.1160/TH10-02-0140. Epub 2010 Dec 6.

PMID:
21136010
24.

Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy.

Kemper B, Bauwens A, Vollmer A, Ketelhut S, Langehanenberg P, Müthing J, Karch H, von Bally G.

J Biomed Opt. 2010 May-Jun;15(3):036009. doi: 10.1117/1.3431712.

PMID:
20615011
25.

Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.

van Brummelen SE, Bauwens AM, Schlösser NJ, Arend SM.

Clin Vaccine Immunol. 2010 Jun;17(6):937-43. doi: 10.1128/CVI.00005-10. Epub 2010 Apr 7.

26.

Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli.

Bielaszewska M, Bauwens A, Greune L, Kemper B, Dobrindt U, Geelen JM, Kim KS, Schmidt MA, Karch H.

Thromb Haemost. 2009 Dec;102(6):1080-92. doi: 10.1160/TH09-07-0499.

PMID:
19967138
27.

Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.

Bauwens AM, van de Graaf EA, van Ginkel WG, van Kessel DA, Otten HG.

J Heart Lung Transplant. 2006 Apr;25(4):416-9.

PMID:
16563971
28.

Validation of a new method to measure hydrogen peroxide in exhaled breath condensate.

Gerritsen WB, Zanen P, Bauwens AA, van den Bosch JM, Haas FJ.

Respir Med. 2005 Sep;99(9):1132-7. Epub 2005 Apr 15.

29.

[Pleural effusion and empyema as complications of pneumonia].

Bauwens AM, de Graaff CS, Boersma WG.

Ned Tijdschr Geneeskd. 2002 Mar 9;146(10):464-9. Dutch.

PMID:
11913110
30.
31.

Atrial flutter with 1:1 conduction after administration of the antimalarial drug mefloquine.

Fonteyne W, Bauwens A, Jordaens L.

Clin Cardiol. 1996 Dec;19(12):967-8.

32.

Blood pressure pattern in the recovery period after coronary artery bypass grafting.

Duprez D, De Buyzere M, Fonteyne W, Bauwens A, De Backer G, Van Nooten G, Clement DL.

Blood Press Monit. 1996 Aug;1(4):339-345.

PMID:
10226257

Supplemental Content

Loading ...
Support Center